Monitoring cytomegalovirus infection by antigenemia assay and two distinct plasma real-time PCR methods after hematopoietic stem cell transplantation.
about
Activation of nucleotide oligomerization domain 2 (NOD2) by human cytomegalovirus initiates innate immune responses and restricts virus replicationCytomegalovirus infection in the bone marrow transplant patientRespiratory virus pneumonia after hematopoietic cell transplantation (HCT): associations between viral load in bronchoalveolar lavage samples, viral RNA detection in serum samples, and clinical outcomes of HCT.Artemisinin-derived dimers have greatly improved anti-cytomegalovirus activity compared to artemisinin monomers.Evaluation of the validity of preemptive therapy against cytomegalovirus disease based on antigenemia assay with a cutoff of 20 positive cells per two slides.Inhibition of human cytomegalovirus replication by artemisinins: effects mediated through cell cycle modulationReal-time PCR assay compared to nested PCR and antigenemia assays for detecting cytomegalovirus reactivation in adult T-cell leukemia-lymphoma patients.Artemisinin-derived dimer diphenyl phosphate is an irreversible inhibitor of human cytomegalovirus replication.Human cytomegalovirus inhibition by cardiac glycosides: evidence for involvement of the HERG gene.Quantification of DNA in plasma by an automated real-time PCR assay (cytomegalovirus PCR kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients.Wnt modulating agents inhibit human cytomegalovirus replication.Comparison of quantitative cytomegalovirus real-time PCR in whole blood and pp65 antigenemia assay: clinical utility of CMV real-time PCR in hematopoietic stem cell transplant recipients.Construction and Evaluation of Cytomegalovirus DNA Quantification System with Real-Time Detection Polymerase Chain Reaction.Increased Level of IFN-γ and IL-4 Spot-Forming Cells on ELISPOT Assay as Biomarkers for Acute Graft-Versus-Host Disease and Concurrent Infections.In vitro combination of anti-cytomegalovirus compounds acting through different targets: role of the slope parameter and insights into mechanisms of Action.Cytomegalovirus Kinetics Following Primary Infection in Healthy Women.Development and evaluation of a quantitative assay detecting cytomegalovirus transcripts for preemptive therapy in allogeneic hematopoietic stem cell transplant recipients.Unique and highly selective anticytomegalovirus activities of artemisinin-derived dimer diphenyl phosphate stem from combination of dimer unit and a diphenyl phosphate moiety.Allotype analysis to determine the origin of cytomegalovirus immunoglobulin-G after allogeneic stem cell transplantation.Dried urine spots for detection and quantification of cytomegalovirus in newborns.Recombinant luciferase-expressing human cytomegalovirus (CMV) for evaluation of CMV inhibitors.A randomized controlled trial of plasma real-time PCR and antigenemia assay for monitoring CMV infection after unrelated BMT.Real-time PCR assays based on distinct genomic regions for cytomegalovirus reactivation following hematopoietic stem cell transplantation.
P2860
Q24293059-FC8FD4A1-B8E1-4B7F-8F44-F89541865F9DQ26771385-02D81370-EB57-4182-95B2-3B70141AEFEEQ33785773-B8B98481-E080-4661-A430-BEB1927ECF1AQ33815957-53E7865B-BEA0-459F-9A1A-372C0A61C5F1Q34989242-432B74AF-7F4D-49EE-86A9-BFEF2B0A6F95Q35746009-DF433647-5515-4076-A115-F6680A4DBA91Q35922545-4D453629-A821-4114-82FC-C03F39C9796AQ36086432-DAE8EFEB-0B22-45D5-860F-B6736C22A31FQ36172394-2D550272-E9B4-46DD-9F5C-9DCF374476A3Q36933563-B1B6868A-665C-4495-B385-DAEEEF7BE0E9Q37026623-0C0674FC-4301-4C2F-92E8-E359BE0CB841Q37284695-B25597D1-CBB4-45F7-ADF6-5D6A32069CA3Q37310186-83998BF8-A86F-4311-A33E-8C29FA240D07Q37512197-0B880D5D-3ECD-4A27-8DBE-ED430DA34380Q37544751-C1165600-95C5-4A54-B678-2EE56E08D84AQ40232738-4AC50C40-06A5-46C8-B082-28EBB0CB2BC3Q40343812-4D3028F5-B963-407C-A1E7-25B5DFA004A0Q41830479-4E1435D1-F0AE-4BFB-86A1-EC4B3E4C09C9Q42182292-5E5F628D-C680-4516-816C-30F7A8DF2DB5Q42236773-7F1F5B65-1227-4956-9AE3-A85B56E62CCFQ42616123-CF7F5F2D-C350-4D35-92AF-F8DC10D5E83AQ43228476-5FF2AC00-5E96-4B57-B35F-8283BB442FB8Q43883386-3F42BFA4-0DAD-4D80-92B7-3E9B3279C153
P2860
Monitoring cytomegalovirus infection by antigenemia assay and two distinct plasma real-time PCR methods after hematopoietic stem cell transplantation.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Monitoring cytomegalovirus inf ...... tic stem cell transplantation.
@en
Monitoring cytomegalovirus inf ...... tic stem cell transplantation.
@nl
type
label
Monitoring cytomegalovirus inf ...... tic stem cell transplantation.
@en
Monitoring cytomegalovirus inf ...... tic stem cell transplantation.
@nl
prefLabel
Monitoring cytomegalovirus inf ...... tic stem cell transplantation.
@en
Monitoring cytomegalovirus inf ...... tic stem cell transplantation.
@nl
P2093
P2860
P356
P1476
Monitoring cytomegalovirus inf ...... tic stem cell transplantation.
@en
P2093
Japan Hematology and Oncology Clinical Study Group (J-HOCS)
S Miyakoshi
P2860
P2888
P304
P356
10.1038/SJ.BMT.1703661
P407
P577
2002-09-01T00:00:00Z
P5875
P6179
1023301467